Waystar's First Test Since Wall Street Trimmed Expectations by Forty Percent

Waystar Holding Corp reports first-quarter 2026 earnings after the close on April 29, with Wall Street expecting the healthcare payments software provider to deliver its strongest year-over-year growth in recent quarters. The central question: can management sustain the momentum that drove three consecutive beats through mid-2025, or will the Q4 miss that sent shares tumbling prove to be the start of a new pattern? For a company trading well below its 100-day and 200-day moving averages, this report carries unusual weight in determining whether the stock can reclaim lost ground or faces further technical deterioration.

Part 1: Earnings Preview

Waystar Holding Corp operates a cloud-based revenue cycle management platform that automates claims processing, payment posting, denials management, and patient billing for healthcare providers and payers across the United States. The company's software aims to simplify complex administrative workflows in the fragmented U.S. healthcare system, with key performance drivers including annual recurring revenue growth, client retention rates, and platform transaction volume.

Waystar reports Q1 2026 results after the close on April 29, with analysts expecting $0.35 per share on revenue of approximately $312 million. The company most recently reported $0.31 per share for Q4 2025, missing the $0.35 consensus and breaking a three-quarter streak of beats. The current estimate represents +20.69% year-over-year growth compared to the $0.29 reported in Q1 2025, marking the strongest expected growth rate in the company's recent history.

Three key themes define this earnings story heading into the release:

Revenue Cycle Automation Adoption: Healthcare providers continue to face mounting administrative costs and reimbursement complexity, driving demand for Waystar's automation solutions. Investors will watch for commentary on new client wins, expansion with existing customers, and average revenue per client—metrics that signal whether the company is successfully capturing market share in the large but fragmented healthcare technology market.

Integration Execution and Cross-Selling: Following recent acquisitions, the focus shifts to how effectively Waystar integrates new capabilities and cross-sells additional products to its existing base. The pace of add-on product adoption and platform transaction volume growth will provide insight into whether the company can drive meaningful expansion revenue beyond new logo wins.

Profitability Trajectory: With adjusted EBITDA margin under scrutiny, analysts are watching whether Waystar can scale profitably while investing in product development and sales capacity. Any guidance on margin expansion or commentary about operating leverage will be critical for a stock trading at a forward P/E of 14.77.

Analyst commentary ahead of the release reflects cautious optimism tempered by the Q4 disappointment. Zacks Research notes that the Most Accurate Estimate of $0.39 sits above the consensus, resulting in a positive Earnings ESP of +1.45%—a signal that analysts with the latest information have become more bullish. Combined with a Zacks Rank of #2 (Buy), the firm's proprietary model suggests a nearly 70% probability of an earnings beat. However, the consensus EPS estimate has been revised only 0.66% higher over the past 30 days, indicating modest rather than surging confidence. Multiple firms trimmed price targets following the Q4 miss, with the average now at $36.65, and the sentiment trend has deteriorated as one analyst downgraded from Buy to Hold.

Part 2: Historical Earnings Performance

Waystar's earnings track record shows a company that consistently exceeded expectations through mid-2025 before stumbling in the most recent quarter. Over the past four quarters, the company beat consensus estimates three times and missed once, with the Q4 2025 miss standing out as a notable departure from the prior pattern.

The beats were modest but consistent: Q1 2025 delivered a +3.57% surprise ($0.29 vs. $0.28 expected), Q2 2025 posted a +3.33% surprise ($0.31 vs. $0.30), and Q3 2025 produced the strongest outperformance with a +6.67% surprise ($0.32 vs. $0.30). These results suggested improving operational execution and conservative guidance.

The pattern broke in Q4 2025, when Waystar reported $0.31 against a $0.35 estimate—an -11.43% miss that marked the company's first significant shortfall. This miss was particularly notable given the magnitude of the disappointment and the fact that it came after three consecutive quarters of beats, raising questions about whether it represents a one-time stumble or signals emerging challenges in the business. The upcoming Q1 report will be critical in determining whether management can return to the beat-and-raise cadence that characterized most of 2025.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

Waystar typically reports earnings after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual numbers.

Historical price behavior around Waystar earnings reveals significant volatility, with the stock averaging an 8.36% intraday range on Day +1 and a 5.97% absolute move following the release. The most dramatic reaction came after the February 2026 report (Q4 2025 results), when shares surged 8.48% on Day 0 in anticipation, then added another 4.52% on Day +1 despite the earnings miss—suggesting the market had braced for worse or found encouragement in management's commentary.

The October 2025 report (Q3 2025) showed the opposite pattern: a muted 0.33% Day 0 move followed by a sharp -6.46% decline on Day +1, indicating the beat failed to impress or guidance disappointed. Earlier reports in 2025 generally produced positive Day +1 moves ranging from 3.76% to 10.47%, with the April and August 2025 releases both delivering double-digit intraday ranges exceeding 10%.

The 1.82% average Day 0 move is relatively modest, but the 7.35% average Day 0 range indicates substantial intraday volatility even before results drop. Investors should prepare for meaningful price swings, with historical data suggesting the Day +1 reaction tends to be larger and more directional than the anticipatory trading on Day 0.

Part 2.2: Options Market Expected Move

The options market is pricing a 10.61% expected move through the May 15 expiration (17 days out), implying a range of $22.55 to $27.91. This expected move is notably larger than the 5.97% average absolute Day +1 move observed historically, suggesting options traders are anticipating above-average volatility for this particular release—likely reflecting uncertainty following the Q4 miss and the stock's technical weakness heading into the report.

Part 3: What Analysts Are Saying

Wall Street maintains a bullish stance on Waystar despite recent price weakness, with the consensus rating at 4.76 out of 5.0—firmly in Buy territory. The analyst community includes 21 Strong Buy ratings and 2 Moderate Buy ratings, offset by just 2 Hold ratings and zero Sell recommendations among the 25 analysts covering the stock. The average price target of $36.00 implies 42.7% upside from the current $25.23 price, with a high target of $44.00 and a low of $27.00 providing a wide range of outcomes.

However, sentiment has deteriorated over the past month, with the average recommendation slipping from 4.83 to 4.76 as one analyst moved from Buy to Hold following the Q4 disappointment. This marks a subtle but notable shift in conviction, even as the overwhelming majority of analysts maintain bullish ratings. The price target range suggests analysts see significant value at current levels but acknowledge execution risk, with the low target of $27.00 sitting just 7% above the current price—a relatively modest margin of safety for a stock with a Strong Buy-heavy rating profile.

The deterioration in sentiment appears measured rather than dramatic, indicating analysts are taking a wait-and-see approach rather than abandoning their bullish thesis. The upcoming earnings report will be critical in determining whether the analyst community reaffirms its conviction or whether additional downgrades and target cuts follow if the company fails to demonstrate a return to consistent execution.

Part 4: Technical Picture

Waystar enters earnings in a technically challenged position, with the Barchart Technical Opinion registering a 56% Sell signal—unchanged from last week but representing a significant deterioration from the 100% Sell reading one month ago. This suggests the stock has stabilized somewhat after a period of intense selling pressure, but the overall technical picture remains cautious.

Timeframe Analysis:

• Short-term (50% Sell): Moderate sell signal indicates near-term momentum remains negative, though not at extreme levels
• Medium-term (50% Sell): Matching the short-term reading, this suggests consolidation rather than a clear directional trend in the intermediate timeframe
• Long-term (100% Sell): Strong sell signal reflects significant weakness in the longer-term trend, with the stock well below key moving averages

Trend Characteristics: The signal strength is rated as "Good" but the direction is "Weakening," indicating the technical indicators are providing clear readings but those readings point to deteriorating momentum heading into the earnings release.

The stock is trading at $25.23, positioned below its 5-day ($25.31), 10-day ($25.49), 100-day ($27.36), and 200-day ($32.12) moving averages—a configuration that typically signals downtrend conditions. However, the stock has managed to climb above its 20-day ($24.18) and 50-day ($24.67) moving averages, suggesting some short-term stabilization after recent weakness.

The 200-day moving average at $32.12 represents a significant overhead resistance level 27.3% above the current price, while the 100-day at $27.36 provides a nearer-term target. Support appears to have formed around the $24 level, roughly aligned with the 20-day and 50-day averages. The technical setup is cautionary heading into earnings: while the stock has stabilized in recent sessions, it remains in a clear downtrend on longer timeframes and would need a substantial positive surprise to break above the 100-day moving average and shift the technical picture. The combination of weakening momentum signals and positioning below key long-term averages suggests limited technical support if the earnings report disappoints, but also creates potential for an outsized move higher if results and guidance exceed expectations.